The Conversation (0)
Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval
Feb. 13, 2018 09:18AM PST
Medical Device InvestingAbiomed (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the launch of a new indication and Women’s Initiative focused on heart recovery education and awareness. As quoted in the press release: According to the Centers for Disease Control and Prevention (CDC), cardiovascular disease is the number one killer of women …
Abiomed (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the launch of a new indication and Women’s Initiative focused on heart recovery education and awareness.
As quoted in the press release:
According to the Centers for Disease Control and Prevention (CDC), cardiovascular disease is the number one killer of women and causes 35% of deaths (approximately 430,000) in American women over the age of 201. Two causes of death as a result of cardiogenic shock, specific to the female population are PPCM and spontaneous coronary artery dissection (SCAD).
